1

                                                                    EXHIBIT 99.6

                    CONSENT OF J.P. MORGAN SECURITIES INC.

The Board of Directors
Packard BioScience Company
800 Research Parkway
Meriden, Connecticut 06450

     We hereby consent to the use of the opinion letter of J.P. Morgan
Securities Inc. dated July 13, 2001 to the Board of Directors of Packard
BioScience Company (the "Company") included as Annex C to the joint proxy
statement/prospectus which forms a part of the Registration Statement on Form
S-4 of PerkinElmer, Inc. relating to the proposed merger of the Company and a
subsidiary of PerkinElmer, Inc., and to the references to such opinion in such
joint proxy statement/prospectus under the caption "THE MERGER--Opinion of
Packard BioScience's Financial Advisor--J.P. Morgan Securities Inc." In giving
such consent, we do not admit that we come within the category of persons whose
consent is required under Section 7 of the Securities Act of 1933, as amended,
or the rules and regulations of the Securities and Exchange Commission
thereunder, nor do we hereby admit that we are experts with respect to any part
of such Registration Statement within the meaning of the term "experts" as used
in the Securities Act of 1933, as amended, or the rules and regulations of the
Securities and Exchange Commission thereunder.


                                    J.P. MORGAN SECURITIES INC.

                                    By:  /s/ Afshin Taber
                                       ---------------------------------
                                       Name:  Afshin Taber
                                       Title: Vice President



August 17, 2001